Quality assurance of volumetric modulated arc therapy: evaluation and comparison of different dosimetric systems.

PURPOSE: To compare and evaluate different dosimetric techniques and devices for the QA of VMAT plans created by two treatment planning systems (TPSs). METHODS: A total of 50 VMAT plans were optimized for treatment of anatomical sites of various complexities by two TPSs which use rather different approaches to VMAT optimization. Dosimetric plan verifications were performed both as part of commissioning and as patient specific QA of clinical treatments. Absolute point doses were measured for all plans by a micro ion chamber inserted in a dedicated water-filled cylindrical phantom. Delivered dose distributions were verified by four techniques based on different detectors: radiographic and gafchromic films, two systems based on 2D diode arrays and an ion chamber array. Gamma index analysis with various tolerance levels (3%, 3 mm and 3%, 2 mm) was used to analyze differences between calculated and delivered doses. Sensitivity to possible delivery errors was also evaluated for three of the considered devices introducing +/-3 mm shifts along the three directions and a 3 degrees gantry offset. RESULTS: Ion chamber measured point doses were within 3% of calculated ones for 48 out of 50 values. For delivered dose distribution, the average fraction of passed gamma values using 3% and 3 mm criteria was above 95% for both TPSs and all detectors except gafchromic film which yielded on average of 91.4%. For 49 out of 50 plans, a pass-rate above 94% was obtained by at least one of the four techniques. Shrinking the tolerance to 3% and 2 mm, the average pass-rate by all detectors (except film) was still above 95% for one of the two TPSs, but lower for the other one. The detector sensitivity to 3 mm shifts and to gantry angle offset was strongly plan and partially detector dependent: the obtained pass-rate reduction ranged from 2% to 30%. CONCLUSIONS: The presented results for VMAT plans QA assess the reliability of the delivered doses for both TPSs. The slightly lower pass-rate obtained for one of the considered TPS can be attributed to a higher level of complexity of the optimized plans. The results by different dosimetric techniques are coherent, apart from a few measurements by gafchromic films. The detector sensitivity to delivery errors, being strongly plan dependent, is not easy to evaluate.

Calculation of k(Q(clin),Q(msr) ) (f(clin),f(msr) ) for several small detectors and for two linear accelerators using Monte Carlo simulations.

PURPOSE: The scope of this study was to determine a complete set of correction factors for several detectors in static small photon fields for two linear accelerators (linacs) and for several detectors. METHODS: Measurements for Monte Carlo (MC) commissioning were performed for two linacs, Siemens Primus and Elekta Synergy. After having determined the source parameters that best fit the measurements of field specific output factors, profiles, and tissue-phantom ratio, the generalized version of the classical beam quality correction factor for static small fields, k(Q(clin),Q(msr) ) (f(clin),f(msr) ), were determined for several types of detectors by using the egs_chamber Monte Carlo user code which can accurately reproduce the geometry and the material composition of the detector. The influence of many parameters (energy and radial FWHM of the electron beam source, field dimensions, type of accelerator) on the value of k(Q(clin),Q(msr) ) (f(clin),f(msr) ) was evaluated. Moreover, a MC analysis of the parameters that influence the change of k(Q(clin),Q(msr) ) (f(clin),f(msr) ) as a function of field dimension was performed. A detailed analysis of uncertainties related to the measurements of the field specific output factor and to the Monte Carlo calculation of k(Q(clin),Q(msr) ) (f(clin),f(msr) ) was done. RESULTS: The simulations demonstrated that the correction factor k(Q(clin),Q(msr) ) (f(clin),f(msr) ) can be considered independent from the quality beam factor Q in the range 0.68 ± 0.01 for all the detectors analyzed. The k(Q(clin),Q(msr) ) (f(clin),f(msr) ) of PTW 60012 and EDGE diodes can be assumed dependent only on the field size, for fields down to 0.5 × 0.5 cm². The microLion, and the microchambers, instead, must be used with some caution because they exhibit a slight dependence on the radial FWHM of the electron source, and therefore, a correction factor only dependent on field size can be used for fields ≥ 0.75 × 0.75 and ≥ 1.0 × 1.0 cm², respectively. The analysis of uncertainties gave an estimate of uncertainty for the 0.5 × 0.5 cm² field of about 0.7% (1σ) for k(Q(clin),Q(msr) ) (f(clin),f(msr) ) factor and of about 1.0% (1σ) for the field output factor, Ω(Q(clin),Q(msr) ) (f(clin),f(msr) ), of diodes, microchambers, and microLion. CONCLUSIONS: Stereotactic diodes with the appropriate k(Q(clin),Q(msr) ) (f(clin),f(msr) ) are recommended for determining Ω(Q(clin),Q(msr) ) (f(clin),f(msr) ) of small photon beams.

Small field dosimetry correction factors for circular and MLC shaped fields with the CyberKnife M6 System: evaluation of the PTW 60023 microSilicon detector.

The PTW 60023 microSilicon is a new unshielded diode detector for small-field photon dosimetry. It provides improved water equivalence and a slightly larger sensitive region diameter in comparison to previous diode detectors in this range. In this study we evaluated the correction factors relevant to commissioning a CyberKnife System with this detector by Monte Carlo simulation and verified this data by multi-detector measurement comparison. The correction factors required for output factor determination were substantially closer to unity at small field sizes than for previous diode versions (e.g. [Formula: see text] = 0.981 at 5 mm field size which compares with corrections of 5%-6% with other stereotactic diodes). Because of these differences we recommend that corrections to small field output factor measurements generated specifically for the microSilicon detector rather than generic data taken from other diode types should be used with this new detector. For depth-dose measurements the microSilicon is consistent with a microDiamond detector to <1% (global), except at depths <10 mm where the diode gives a significantly lower measurement, by 6%-8% at the surface. For profile measurements, the microSilicon requires negligible corrections except in the low dose region outside the beam, where it underestimates off-axis-ratio (OAR) for small fields and overestimates for large fields. Where this effect is most noticeable at the largest field size and depth (115 mm × 100 mm and 300 mm depth) the microSilicon overestimates OAR by 2.3% (global) in the profile tail. This is consistent with other unshielded diodes.

Determination of consensus k Q values for megavoltage photon beams for the update of IAEA TRS-398.

The IAEA is currently coordinating a multi-year project to update the TRS-398 Code of Practice for the dosimetry of external beam radiotherapy based on standards of absorbed dose to water. One major aspect of the project is the determination of new beam quality correction factors, k Q , for megavoltage photon beams consistent with developments in radiotherapy dosimetry and technology since the publication of TRS-398 in 2000. Specifically, all values must be based on, or consistent with, the key data of ICRU Report 90. Data sets obtained from Monte Carlo (MC) calculations by advanced users and measurements at primary standards laboratories have been compiled for 23 cylindrical ionization chamber types, consisting of 725 MC-calculated and 179 experimental data points. These have been used to derive consensus k Q values as a function of the beam quality index TPR20,10 with a combined standard uncertainty of 0.6%. Mean values of MC-derived chamber-specific [Formula: see text] factors for cylindrical and plane-parallel chamber types in 60Co beams have also been obtained with an estimated uncertainty of 0.4%.

The impact of inter-unit variations on small field dosimetry correction factors, with application to the CyberKnife system.

Small field dosimetry correction factors are usually determined from calculations or measurements using one specific example of a treatment system. The sensitivity of the corrections to inter-unit variation is therefore not evaluated. We propose two methods for this evaluation that could be applied to any system. We use them to assess the variability in [Formula: see text] for the CyberKnife System caused by design changes between pre-M6 and M6 versions, and to the variability in [Formula: see text] and [Formula: see text] resulting from measured beam-data variations across 139 units. We also perform measurements to investigate the differences in [Formula: see text] reported for microchambers in a CyberKnife-specific study versus TRS-483. The results show that [Formula: see text] is smaller for the M6 version than pre-M6 versions by 0.4% for a Farmer chamber, and 0.1% for shorter chambers. The presence or absence of a lead filter within the treatment head had no significant impact on [Formula: see text]. The beam-data analysis showed inter-unit variations in [Formula: see text] of ±0.8% (2 s.d.) for Farmer chambers and ⩽ ±0.5% for shorter cavities (<10 mm) pre-M6, reducing to 0.4% and 0.2% respectively with M6. Inter-unit [Formula: see text] variations for microDiamond and microchambers were ⩽ ±1% at 5 mm field size, except for microchambers with axis perpendicular to the beam where this was > ±2%. Differences of up to 9% were confirmed between Output Factors measured using a microchamber and corrected using TRS-483 [Formula: see text], and a consensus dataset for the same treatment unit determined using multiple detectors and Monte Carlo simulation. A set of practical recommendations for small field dosimetry with the CyberKnife System is derived from these results.

Monte Carlo simulated corrections for beam commissioning measurements with circular and MLC shaped fields on the CyberKnife M6 System: a study including diode, microchamber, point scintillator, and synthetic microdiamond detectors.

Monte Carlo simulation was used to calculate correction factors for output factor (OF), percentage depth-dose (PDD), and off-axis ratio (OAR) measurements with the CyberKnife M6 System. These include the first such data for the InCise MLC. Simulated detectors include diodes, air-filled microchambers, a synthetic microdiamond detector, and point scintillator. Individual perturbation factors were also evaluated. OF corrections show similar trends to previous studies. With a 5 mm fixed collimator the diode correction to convert a measured OF to the corresponding point dose ratio varies between -6.1% and -3.5% for the diode models evaluated, while in a 7.6 mm × 7.7 mm MLC field these are -4.5% to -1.8%. The corresponding microchamber corrections are +9.9% to +10.7% and +3.5% to +4.0%. The microdiamond corrections have a maximum of -1.4% for the 7.5 mm and 10 mm collimators. The scintillator corrections are <1% in all beams. Measured OF showed uncorrected inter-detector differences >15%, reducing to <3% after correction. PDD corrections at d > d max were <2% for all detectors except IBA Razor where a maximum 4% correction was observed at 300 mm depth. OAR corrections were smaller inside the field than outside. At the beam edge microchamber OAR corrections were up to 15%, mainly caused by density perturbations, which blurs the measured penumbra. With larger beams and depths, PTW and IBA diode corrections outside the beam were up to 20% while the Edge detector needed smaller corrections although these did vary with orientation. These effects are most noticeable for large field size and depth, where they are dominated by fluence and stopping power perturbations. The microdiamond OAR corrections were <3% outside the beam. This paper provides OF corrections that can be used for commissioning new CyberKnife M6 Systems and retrospectively checking estimated corrections used previously. We recommend the PDD and OAR corrections are used to guide detector selection and inform the evaluation of results rather than to explicitly correct measurements.

Preliminary study on the use of nonrigid registration for thoraco-abdominal radiosurgery.

The inclusion of organ deformation and movement in radiosurgery treatment planning is of increasing importance as research and clinical applications begin to take into consideration the effects of physiological processes, like breathing, on the shape and position of lesions. In this scenario, the challenge is to localize the target in toto (not only by means of marker sampling) and to calculate the dose distribution as the sum of all the contributions from the positions assumed by the target during the respiratory cycle. The aim of this work is to investigate the use of nonrigid registration for target tracking and dynamic treatment planning, i.e., treatment planning based not on one single CT scan but on multiple CT scans representative of the respiration. Twenty patients were CT scanned at end-inhale and end-exhale. An expert radiation oncologist identified the PTV in both examinations. The two CT data sets per patient were nonrigidly registered using a free-form deformation algorithm based on B-splines. The optimized objective function consisted of a weighted sum of a similarity criterion (Mutual Information) and a regularization factor which constrains the transformation to be locally rigid. Once the transformation was obtained and the registration validated, its parameters were applied to the target only. Finally, the deformed target was compared to the PTV delineated by the radiation oncologist in the other study. The results of this procedure show an agreement between the center of mass as well as volume of the target identified automatically by deformable registration and manually by the radiation oncologist. Moreover, obtained displacements were in agreement with body structure constraints and considerations usually accepted in radiation therapy practice. No significant influence of initial target volume on displacements was found. In conclusion, the proposed method seems to offer the possibility of using nonrigid registrations in radiosurgery treatment planning, even if more cases need to be investigated in order to give a statistical consistency to parameter setup and proposed considerations.

CT-3D rotational angiography automatic registration: a sensitivity analysis.

Preprocessing, binning and dataset subsampling are investigated with regard to simultaneous maximisation of the speed, accuracy and robustness of CT-3D rotational angiography (3DRA) registration. Clinical diagnosis and treatment can both take advantage of this integration, because 3DRA allows the shape of vessel structures to be evaluated three-dimensionally with respect to standard 2D projective angiography. The method for optimising preprocessing, binning and subsampling consisted of independent variation of the corresponding parameters to maximise robustness and speed while maintaining subvoxel accuracy; the latter was computed as the sum of the mean squared errors initially present in the registrations with the errors relative to both binning and subsampling. The results suggest the choice of 256 bins, steps between 14 mm (coarse optimisation) and 2.5 mm (fine optimisation) and bone segmentation by threshold, for binning, subsampling and preprocessing, respectively. The application of this parameter set-up to 50 CT-3DRA registrations resulted in a saving, on average, of 40% of the time with respect to the method previously used, while registration error was maintained within 2 mm (1.97 mm, 90% confidence interval) and robustness was increased, so that no manual initial realignment was needed in 48 registrations. Validation by the registration of images acquired for a head phantom showed subvoxel residual errors. In conclusion, the proposed procedure can be considered a satisfactory strategy to optimise CT-3DRA registration.

Use of novel fibre-coupled radioluminescence and RADPOS dosimetry systems for total scatter factor measurements in small fields.

A dosimetry system based on Al2O3:C radioluminescence (RL), and RADPOS, a novel 4D dosimetry system using microMOSFETs, were used to measure total scatter factors, (S(c,p))(f(clin))(det), for the CyberKnife robotic radiosugery system. New Monte Carlo calculated correction factors are presented and applied for the RL detector response for the 5, 7.5 and 10 mm collimators in order to correct for the detector geometry and increased photoelectric cross section of Al2O3:C relative to water. For comparison, measurements were also carried out using a micro MOSFET, PTW60012 diode and GAFCHROMIC(®) film (EBT and EBT2). Uncorrected (S(c,p))(f(clin))(det) were obtained by taking the ratio of the detector response for each collimator to that for the 60 mm diameter reference field. Published Monte Carlo calculated correction factors were applied to the RADPOS, microMOSFET and diode detector measurements to yield corrected field factors, Ω(f(clin),f(msr))(Q(clin),Q(msr)), following the terminology of a recent formalism introduced for small and composite field relative dosimetry. With corrections, the RL measured Ω(f(clin),f(msr))(Q(clin),Q(msr)) were 0.656 ± 0.002, 0.815 ± 0.002 and 0.865 ± 0.003 for the 5, 7.5 and 10 mm collimators, respectively. This was in good agreement with RADPOS corrected field factors of 0.650 ± 0.010, 0.816 ± 0.024 and 0.867 ± 0.010 for the 5, 7.5 and 10 mm collimators, respectively. Both RL and RADPOS total scatter factors agreed within approximately two standard deviations of the GAFCHROMIC film values (average of EBT and EBT2) of 0.640 ± 0.006, 0.806 ± 0.007 and 0.859 ± 0.09. Corrected total scatter factors for all dosimetry systems agreed within one standard deviation for collimator sizes 10-60 mm. Our study suggests that the microMOSFET/RADPOS and optical fibre-coupled RL dosimetry system are well suited for total scatter factor measurements over the entire range of field sizes, provided that appropriate correction factors are applied for the collimator diameters smaller than 10 mm.

Calibration of a mosfet detection system for 6-MV in vivo dosimetry.

PURPOSE: Metal oxide semiconductor field-effect transistor (MOSFET) detectors were calibrated to perform in vivo dosimetry during 6-MV treatments, both in normal setup and total body irradiation (TBI) conditions. METHODS AND MATERIALS: MOSFET water-equivalent depth, dependence of the calibration factors (CFs) on the field sizes, MOSFET orientation, bias supply, accumulated dose, incidence angle, temperature, and spoiler-skin distance in TBI setup were investigated. MOSFET reproducibility was verified. The correlation between the water-equivalent midplane depth and the ratio of the exit MOSFET readout divided by the entrance MOSFET readout was studied. MOSFET midplane dosimetry in TBI setup was compared with thermoluminescent dosimetry in an anthropomorphic phantom. By using ionization chamber measurements, the TBI midplane dosimetry was also verified in the presence of cork as a lung substitute. RESULTS: The water-equivalent depth of the MOSFET is about 0.8 mm or 1.8 mm, depending on which sensor side faces the beam. The field size also affects this quantity; Monte Carlo simulations allow driving this behavior by changes in the contaminating electron mean energy. The CFs vary linearly as a function of the square field side, for fields ranging from 5 x 5 to 30 x 30 cm2. In TBI setup, varying the spoiler-skin distance between 5 mm and 10 cm affects the CFs within 5%. The MOSFET reproducibility is about 3% (2 SD) for the doses normally delivered to the patients. The effect of the accumulated dose on the sensor response is negligible. For beam incidence ranging from 0 degrees to 90 degrees, the MOSFET response varies within 7%. No monotonic correlation between the sensor response and the temperature is apparent. Good correlation between the water-equivalent midplane depth and the ratio of the exit MOSFET readout divided by the entrance MOSFET readout was found (the correlation coefficient is about 1). The MOSFET midplane dosimetry relevant to the anthropomorphic phantom irradiation is in agreement with TLD dosimetry within 5%. Ionization chamber and MOSFET midplane dosimetry in inhomogeneous phantoms are in agreement within 2%. CONCLUSION: MOSFET characteristics are suitable for the in vivo dosimetry relevant to 6-MV treatments, both in normal and TBI setup. The TBI midplane dosimetry using MOSFETs is valid also in the presence of the lung, which is the most critical organ, and allows verifying that calculation of the lung attenuator thicknesses based only on the density is not correct. Our MOSFET dosimetry system can be used also to determine the surface dose by using the water-equivalent depth and extrapolation methods. This procedure depends on the field size used.

Evaluation of linear accelerator radiosurgical techniques using biophysical parameters (NTCP and TCP).

PURPOSE: Several irradiation techniques are compared with regard to normal tissue complication probability and tumor control probability. METHODS AND MATERIALS: Normal tissue complication probability is calculated using a model based on the "critical element architecture." The probability of controlling an inhomogeneously irradiated tumor is calculated using a model that takes into account the heterogeneity of tumors (different radiosensitivity of clonogens within the tumor and the varying number of clonogens among patients with the same kind of tumor). The ratio of tumor control probability to normal tissue complication probability (therapeutic gain factor) at different levels of dose has been used as a score for the analysis of various irradiation techniques. RESULTS: The best irradiation techniques depends on many factors: irradiation genometry, irradiation field size, choice of the reference isodose, and it is dictated by the pathology of the lesions (noninfiltrating radioresistant tumors, infiltrating radioresistant tumors, noninfiltrating radiosensitive tumors, infiltrating radiosensitive tumors, arterovenous malformations). For the irradiation of the artero-venous malformations it is proposed to insert on the supplemental collimator a flattening filter to reduce the probability of inducing a poorly syncronized obliterative effect. CONCLUSION: We propose that for each kind of pathology to be treated radiosurgically, a proper irradiation strategy should be used.

A simple method to verify in vivo the accuracy of target coordinates in linear accelerator radiosurgery.

PURPOSE: A simple method that verifies the coincidence of the isocenter with the center of the target volume in radiosurgery treatment conditions is described. The accuracy is compared to that of accepted computerized procedures employing fiducial markers. METHODS AND MATERIALS: The center of the beam is identified by a cylindrical localizer, fixed to the plate of the supplemental collimator, with a 2 x 50 mm tungsten rod coincident with the beam axis and is projected onto the x-ray portal verification films. Prior to irradiation, the coordinates of the intersection of the beams axes, which is in a known spatial relationship with the isocenter, are read directly on portal x-ray films and their coincidence with the coordinates set during patient positioning, is checked. RESULTS: The mean displacement in AP, Lat, and Vert coordinates respectively, over 84 patients, between the coordinates calculated by the computerized procedure employing fiducial markers and the coordinates calculated by using the rulers was 0.3 +/- 0.4 mm. CONCLUSIONS: From the results obtained with the two methods we can conclude that rulers method can be used as a fast indirect control of the position of the radiation isocenter. Moreover, the dimensions of the radiation field and the correct alignment of the tertiary circular collimator can be also documented.

Diagnostic features of body surface potential maps in patients with myocardial ischemia and normal resting 12-lead electrocardiograms.

Body surface maps recorded from 35 ischemic patients with normal resting 12-lead electrocardiograms were compared with those obtained from 36 age- and sex-matched normal subjects. From instantaneous maps of each subject 187 variables were derived relating to the configuration (80 variables) and magnitude (104 variables) of the potential distribution and duration of the electrocardiographic intervals (3 variables). By using stepwise discriminant analysis we selected 3 variables whose linear combination enabled us to correctly allocate 91% of the study population (jacknife procedure; specificity 92%, sensitivity 91%). To substantiate the validity of the results the discriminant function was tested on a new independent population consisting of 27 ischemic patients and 54 normal subjects from another laboratory. A proper allocation was obtained in 86% of the cases (specificity 87%, sensitivity 85%). The large number of correctly classified ischemic patients and the repeatability of the results indicate that the adopted criteria are good markers of ischemic heart disease.

From radiotherapy to stereotactic radiosurgery: physical and dosimetrical considerations.

The aim of this presentation is to analyse the mechanical and dosimetrical parameters of the linear accelerator used in stereotactic radiosurgery. The use of the thimble and Markus chambers, TL and film in small field dosimetry are investigated. To determine the optimal irradiation technique and dose distribution, the dose volume to healthy tissue is considered.

Analysis of dosimetric measurements in linac radiosurgery calibration.

The aim of this paper is to analyse the dosimetric parameters of a linear accelerator used in radiosurgery treatments. The influence of these parameters on the resulting dose distribution are basic for delivering the predefined dose to the vascular or oncological target volume. Several dosimetric methods have been used to define the output factors for small fields. The thimble and the Markus chambers, TLD and film dosimetry are investigated; all these dosimetric systems give reliable and almost similar results if used in the correct way. In the determination of tissue maximum ratio (TMR) the response curves obtained by ionometric and film dosimetry were investigated. For TMR determination the use of the Markus chamber and the correction factors to be applied as a result of the small dimension of the field were also investigated.

Dose verification of an IMRT treatment planning system with the BEAM EGS4-based Monte Carlo code.

Intensity modulated radiation therapy (IMRT) has been increasingly used in radiotherapy departments during the last several years. A major advantage of IMRT in comparison to traditional three-dimensional conformal radiotherapy is the higher capability in providing dose distributions that conform very tightly to the target even for very complex shapes such as, for instance, concave regions. This results in a significant sparing of adjacent normal tissues. Different types of algorithms are employed in the IMRT dose calculation, from the simple pencil beam method, such as the finite-size pencil beam algorithm, to the more sophisticated algorithms, such as the kernel-based convolution/superposition ones. With the latter ones, electronic disequilibrium and inhomogeneities are better dealt with in comparison to the correction-based models like pencil beam. Nevertheless, even these types of algorithms may have some approximations that can potentially affect the dose results, especially considering that in an IMRT plan small segments or beamlets may be present for which electronic disequilibrium and inhomogeneities effects are of paramount importance. The goal of this work was to determine the accuracy in monitor units (MU) and dose distribution calculation of the algorithm implemented in the commercial treatment planning system PINNACLE3 (P3), for two IMRT plans with 6 MV photon beams. This system is based on a convolution/superposition with the Collapsed Cone approximation algorithm. The "BEAM" Monte Carlo (MC) code was employed as a benchmark in comparing the MU calculation and the dose distribution of P3. The model used to calculate the MU, with the separation of collimator scatter from the phantom scatter, valid for broad beams, was verified for narrow and irregular segments. The attention was focused on the way P3 calculates output factors (OF). A difference of 8% compared to MC was found for a particularly narrow segment analyzed. A dependence of the results on field size was found. For the complete plan, the agreement of dose distribution and MU calculation with MC results (affected by a dose uncertainty less than 0.5%) is very good: the dose difference at isocenter is 2.1% (1 standard deviation) for a "Prostate" site and 2.9% (1 standard deviation) for the "Head and Neck" site.

Photon dose calculation of a three-dimensional treatment planning system compared to the Monte Carlo code BEAM.

The purpose of this work is to compare the photon dose calculation of a commercially available three-dimensional (3D) treatment planning system based on the collapsed cone convolution technique against BEAM, a Monte Carlo code that allows detailed simulation of a radiotherapy accelerator. The first part of the work is devoted to the commissioning of BEAM for a 6 MV photon beam and to the optimization of the linac description to fit the experimental data. This step also involves a comparison with radiochromic film data on an inhomogeneous phantom built to simulate electronic nonequilibrium conditions. Commissioning the selected photon beams required a careful description of the treatment head and the fine tuning of physical parameters such as electron beam energy and radius. The second part shows the dose comparison for real patient's CT data sets: A mediastinal treatment and a breast treatment were simulated. Doses in terms of absolute values per monitor unit were calculated based on the BEAM simulation of the CT data sets. For comparisons of real-patient cases, differences between the treatment planning system and BEAM ranged from 0 to 2.6% and were within +/-2 standard deviations for the dose calculated at the prescription point. Dose-volume histogram analysis indicated that there is no consistent difference between the Monte Carlo and the convolution calculations. On the basis of the results presented in this study, we can conclude that the CCC algorithm is capable of giving results absolutely comparable to those of a Monte Carlo calculation, as far as common 3D radiotherapy planning is concerned.

Use of a new type of radiochromic film, a new parallel-plate micro-chamber, MOSFETs, and TLD 800 microcubes in the dosimetry of small beams.

The dosimetry of the fields usually employed in radiosurgery requires the use of small detectors to measure Total Scatter Factor (Sc,p), Tissue Maximum Ratio (TMR), Percentage Depth Dose (PDD), and Off Axis Ratio (OAR). In this paper new dosimeters are investigated: a new type of radiochromic film, a micro parallel-plate chamber (filled with both air and tetramethylsilane, TMS), MOSFETs, and TLD-800 microcubes. Their behavior has been compared with the response of radiographic film and with the values obtained with BEAM Monte Carlo simulation. The experimental data confirm that dosimetry with radiochromic films and TLDs gives consistent results for all beam diameters. The parallel-plate micro chamber underestimates the Sc,p for the smallest field diameters (4.4 mm and 6.7 mm); MOSFETs show an over-estimation for the Sc,p of the 4.4 mm, 6.7 mm, and 10.5 mm field diameters. BEAM Monte Carlo simulation employing a parallel beam and a standard 6 MV x-ray spectrum has been used to obtain a correction factor as a function of the field size for both the parallel-plate micro chamber and MOSFETs. High accuracy measurements of PDD and TMR have been made in a water phantom both with radiochromic film and with the micro parallel-plate chamber and have been compared with the data computed by BEAM Monte Carlo simulation. The latter dosimeter is preferred because of the quicker and simpler use and because it gives immediate readout. Measurements of OAR made with radiochromic films and with radiographic films give differences in the 80%-20% penumbra width within 0.6 mm for field diameters ranging from 4.4 mm to 19 mm.

A simple method for bremsstrahlung spectra reconstruction from transmission measurements.

A new method for evaluation of bremsstrahlung spectra from transmission measurements has been developed. In this method some very well known facts relating to thick target bremsstrahlung spectra are a priori included in the calculation procedure. Some characteristics of the method are preliminarily illustrated on a 6 MV therapy linear accelerator.

Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update.

One hundred eighty patients affected by cerebral arteriovenous malformations (AVMs) underwent radiosurgical treatment in our department. One hundred fifty-three patients have been treated with complete irradiation of the entire AVM nidus. In 27 patients (with large and/or three-dimensional irregular target volumes), only part of the nidus was covered with a dose adequate for obliteration. Follow-up ranged from 88 to 1 months (mean, 43.1 mo). Angiographic control was performed at 12, 24, and 36 months until complete obliteration was attained. The complete obliteration rate was 46% at 1 year and 80% at 2 years. We observed 15 hemorrhages after treatment, and five patients died from them. No bleeding took place after complete angiographic obliteration. The aim of this study is to evaluate the effect of irradiation on bleeding risk after radiosurgery and before complete obliteration. Inclusive parameters of patients considered at risk were as follows: 1) all patients in the time lapse between irradiation and demonstrated complete angiographic obliteration; 2) all patients in the time lapse between irradiation and definitive treatment either by surgery or embolization; and 3) all patients in the time lapse between irradiation and death. These groups include all irradiated patients who still had incompletely obliterated AVMs. They were stratified starting from 0 time (the date of radiosurgery), and the hemorrhages were evaluated every 6 months. In totally irradiated cases, the bleeding risk decreased from 4.8% in the first 6 months after radiosurgery to 0% starting from the 12th month of the follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)